AP-180 inhibitors are a group of compounds with the potential to influence the function of the AP-180 protein. AP-180, encoded by the SNAP91 gene in humans, plays a critical role in clathrin-mediated endocytosis, a cellular process used to internalize substances from the cell surface into vesicles. AP-180 facilitates the assembly of clathrin coats on the vesicles during this process. Therefore, compounds that can inhibit the function of AP-180 can potentially affect endocytosis and, consequently, the cellular intake of various molecules.Inhibition of AP-180 can occur through different mechanisms. Direct inhibitors might bind to the protein and hinder its ability to interact with clathrin or other components involved in endocytosis. This could prevent AP-180 from facilitating the assembly of clathrin coats, thereby affecting the formation of endocytic vesicles. Alternatively, an inhibitor could bind to the clathrin binding domain on AP-180, which would also prevent the formation of clathrin coats.
Indirect inhibitors of AP-180 might act by affecting the cellular pathways that control the expression, localization, or post-translational modification of the protein. A compound could inhibit the production of AP-180 by interfering with the transcription or translation of the SNAP91 gene. Alternatively, an inhibitor could affect the post-translational modifications of AP-180, which might be important for its function and localization within the cell. Furthermore, compounds that generally affect endocytosis by targeting other components of the process could also indirectly influence the function of AP-180. AP-180 inhibitors constitute a diverse class of compounds with the potential to influence the function of AP-180 and, consequently, the process of clathrin-mediated endocytosis. Depending on their specific mechanisms of action, these inhibitors can have a variety of effects on cellular function. The field of AP-180 inhibitors is still evolving, and further research is needed to fully understand their potential effects and applications.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-Methyladenine (Autophagy Inhibitor, 3-MA) is known to inhibit PI3K, which can affect various cellular processes including endocytosis. It might indirectly influence the function or activity of AP-180. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
As a noncompetitive inhibitor of dynamin, Dynasore could potentially influence endocytosis and thereby AP-180 function. | ||||||
Dansylcadaverine | 10121-91-2 | sc-214851 sc-214851A sc-214851B | 100 mg 250 mg 1 g | $52.00 $89.00 $240.00 | 4 | |
Dansylcadaverine is used to inhibit receptor-mediated endocytosis, a process in which AP-180 is involved. It could therefore potentially influence its function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is known to inhibit tyrosine kinases, which could indirectly influence the phosphorylation state and function of proteins involved in endocytosis, possibly including AP-180. | ||||||